Oxford-AstraZeneca vaccine

Photo: Courtesy
Covid-19 in Bangladesh

Bangladesh gets over 8m AstraZeneca jabs from Japan, UK

The government has so far achieved 32% of the overall vaccination target

Staff member handles AstraZeneca COVID-19 vaccines in storage at Region Hovedstaden's Vaccine Center, Copenhagen, Denmark February 11, 2021. Ritzau Scanpix/Liselotte Sabroe via REUTERS
Coronavirus chronicle

US to share up to 60 mln AstraZeneca vaccine doses globally

Vials labelled "Covid-19 Coronavirus Vaccine" and syringes are seen in front of a displayed EU flag in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Australia to continue AstraZeneca vaccine rollout, review EU findings

A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca
Coronavirus chronicle

Questions about AstraZeneca jab linger

The production of line for vials of Covishield at the Serum Institute of India Ltd. Hadaspar plant in Pune, India, on Jan. 22. Photographer: Dhiraj Singh/Bloomberg
Coronavirus chronicle

Covax expects full vaccine supplies from India's Serum in May, says Unicef

A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca
Analysis

Missteps could mar long-term credibility of AstraZeneca shot

Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo
Coronavirus chronicle

AstraZeneca may have provided incomplete efficacy data from latest Covid-19 trial: NIAID

A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca
Coronavirus chronicle

AstraZeneca vaccine 79% effective in US trial

AstraZeneca logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. Picture taken March 16, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Analysis

How worried should we be about reports of blood clots and AstraZeneca's vaccine?

A vial with the AstraZeneca's coronavirus disease (COVID-19) vaccine is pictured in Berlin, Germany, March 16, 2021. REUTERS/Hannibal Hanschke
Coronavirus chronicle

Health experts pore over AstraZeneca safety data as Europe reels from vaccine suspensions

Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Netherlands halts use of AstraZeneca Covid-19 vaccine

FILE PHOTO: A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Spanish regions halt AstraZeneca shots over blood clot concerns

There was also a mock drill of conducting vaccination and reporting and review meetings at the block, district and state levels. Picture: Hindustan Times
Coronavirus chronicle

No clotting case in India after Oxford dose